Federated Hermes Strategic Div Gr C holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Federated Hermes Strategic Dividend Growth Fund, Inc - Class C Shares LEICX
- NAV / 1-Day Return 21.10 / −1.36 %
- Total Assets 757.3M
-
Adj. Expense Ratio
1.900%
- Expense Ratio 1.900%
- Distribution Fee Level High
- Share Class Type Level Load
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment 1,500
- Status Open
- TTM Yield 0.79%
- Turnover 115%
USD | NAV as of Jun 18, 2026 | 1-Day Return as of Jun 18, 2026, 12:11 AM GMT+0
Morningstar’s Analysis LEICX
Will LEICX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the LEICX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of LEICX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 29.7
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
JPMorgan Chase & Co | 3.49 | 26M | Financial Services |
Darden Restaurants Inc | 3.27 | 24M | Consumer Cyclical |
Deutsche Telekom AG | 3.12 | 23M | Communication Services |
ConocoPhillips | 3.08 | 23M | Energy |
Paychex Inc | 3.04 | 23M | Technology |
Bank of America Corp | 2.91 | 22M | Financial Services |
Entergy Corp | 2.87 | 21M | Utilities |
Amgen Inc | 2.67 | 20M | Healthcare |
Abbott Laboratories | 2.63 | 20M | Healthcare |
Koninklijke KPN NV | 2.61 | 19M | Communication Services |
United States